New drug combo shows promise for tough-to-treat lymphoma in japanese patients
NCT ID NCT04661007
First seen Jan 05, 2026 · Last updated Jun 16, 2026 · Updated 24 times
Summary
This study tests the safety and effectiveness of tafasitamab alone or combined with other drugs (lenalidomide, parsaclisib, or R-CHOP) in about 72 Japanese adults with Non-Hodgkin lymphoma, including diffuse large B-cell lymphoma. The goal is to find the best doses and see if the treatment shrinks tumors. Participants have relapsed or refractory disease or are newly diagnosed. The study is active but not recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Cancer Center Hospital
Aichi, 464 8681, Japan
-
Chiba Cancer Center
Chiba, 260-8717, Japan
-
Iuhw Narita Hospital
Narita, 286-8520, Japan
-
Japanese Red Cross Nagoya Daini Hospital
Nagoya, 466-8650, Japan
-
Kanagawa Cancer Center
Yokohama, 241-8515, Japan
-
Kindai University Hospital
Sayama, 589-8511, Japan
-
Kobe City Medical Center General Hospital
Hyōgo, 650-0047, Japan
-
Kyushu University Hospital
Fukuoka, Japan
-
Mie University Hospital
Tsu, 514-0001, Japan
-
National Cancer Center Hospital
Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East
Chiba, 277-8577, Japan
-
National Hospital Organization Kyushu Cancer Center
Fukuoka, 811-1395, Japan
-
Nho Disaster Medical Center
Tachikawa, 190-0014, Japan
-
Nho Hokkaido Cancer Center
Sapporo, 003-0804, Japan
-
Nho Kumamoto Medical Center
Kumamoto-ken, 860-008, Japan
-
Nho Okayama Medical Center
Okayama, 701-1192, Japan
-
Nho Shikoku Cancer Center
Matsuyama, 791-0280, Japan
-
Osaka University Hospital
Suita-shi, 565-0871, Japan
-
Saitama Medical Center
Saitama-shi, 330-8503, Japan
-
The Cancer Institute Hospital of Jfcr
Kōtoku, 135-8550, Japan
-
Tohoku University Hospital
Miyagi, 980-8574, Japan
-
Tokai University Hospital
Kanagawa, 259-1193, Japan
-
University of Fukui Hospital
Fukui, 910-1193, Japan
Conditions
Explore the condition pages connected to this study.